Skip to main content
. 2016 Apr 13;7(21):30323–30335. doi: 10.18632/oncotarget.8730

Figure 1. Chemical structures of the BMS-8, -37, -202 and -242 inhibitors of PD-1/PD-L1 interaction.

Figure 1

Compound numbering according to patent application WO2015034820 (A1).

HHS Vulnerability Disclosure